DR. CHUNG KHAN, MD

Plain English
This study looked at how sleep patterns in veterans with post-traumatic stress disorder (PTSD) relate to their risk of suicidal thoughts. Researchers used a simple device that recorded the veterans' sleep from home without requiring any interaction. They found that veterans at high risk for suicide went to bed 63 minutes earlier than those at low risk, and that poorer sleep was linked to more severe suicidal thoughts. Who this helps: This helps veterans struggling with PTSD and their healthcare providers.

Plain English
Researchers studied two methods of anesthesia used during brain surgery for gliomas, focusing on whether awake craniotomy (AC) is better than general anesthesia (GA). They found that both methods had similar results in terms of tumor removal, survival rates, and safety, but awake craniotomy was more expensive, costing about $2,175 extra per case. This is important because it helps doctors decide which method might work best for their patients, balancing between monitoring brain function during surgery and the overall cost and outcomes. Who this helps: Patients and their doctors.

Plain English
This study looked at a type of blood cancer called follicular lymphoma (FL) to see if patients with low-grade but fast-growing tumors need different treatment compared to those with slower-growing tumors. They examined 145 patients and found that those with low-grade/high proliferation index (LG/HP) tumors had a median progression-free survival that was worse than those with low-grade/low proliferation index (LG/LP) tumors, but the difference wasn't strong enough to be statistically meaningful. This matters because it suggests that patients with LG/HP FL might not need different treatments than those with slower-growing forms of the disease. Who this helps: This helps patients with follicular lymphoma and their doctors when deciding on treatment options.

Plain English
This study looked at a new method for calculating the energy levels of molecules by using a different mathematical framework than the traditional approach in quantum chemistry. Researchers found that this new method offers better accuracy in predicting vibrational energies—specifically, it produces significant improvements by considering both the position and momentum of atoms in a three-particle system. This matters because more accurate calculations can lead to better understanding and predictions in molecular behavior, which is crucial for many applications in chemistry and materials science. Who this helps: This helps researchers and scientists working in quantum chemistry and molecular physics.

Plain English
The study examined how often keloids, which are painful raised scars, come back after being surgically removed and treated with radiation over two years. Out of 17 patients treated, 11 (65%) saw their keloids return after either surgery or radiation, while 7 (35%) did not have a recurrence. These findings help doctors better understand the effectiveness of this treatment method and guide future approaches for managing keloids, especially in Pakistani patients. Who this helps: This benefits patients suffering from keloids and their healthcare providers.

Plain English
This study examined harmful pollutants called environmentally persistent free radicals (EPFRs) found in air particles from various sources in Islamabad, Pakistan. Researchers discovered that burning solid fuels like biomass and coal is a major way these radicals enter the air, and that they can last between 38 to 67 days in the environment. Understanding how these pollutants behave is crucial because it helps create better strategies to reduce their health risks. Who this helps: This benefits patients and communities exposed to air pollution.

Plain English
This study looked at how well two treatments, epcoritamab and glofitamab, work for patients with aggressive B-cell lymphoma who have not responded to previous therapies. Out of 245 patients, about half responded to these treatments, with epcoritamab showing a response rate of 51% and glofitamab at 53%. On average, patients survived 7.8 months after treatment, but those with low levels of a specific target (CD20) had worse outcomes. Who this helps: This research benefits patients with aggressive B-cell lymphoma, especially those who have already tried other treatments without success.

Plain English
This study looked at a rare case of a 56-year-old man who had both chronic lymphocytic leukemia (CLL) and myasthenia gravis (MG). The patient had serious symptoms like difficulty breathing and swallowing, and despite receiving aggressive treatment, his MG symptoms were persistent until he started a new medication called rituximab, which led to improvement. This case highlights the importance of quickly identifying and treating CLL in patients with MG to help alleviate their neurological symptoms and improve their overall health. Who this helps: This benefits patients with chronic conditions like CLL and MG, as well as their doctors.

Plain English
This study focused on improving the way researchers can study the spread of tumors using fruit flies, which are commonly used in cancer research. The researchers developed a method to repeatedly transplant tumors from fruit fly brains, allowing them to grow and track how these tumors spread to other organs, like ovaries and the brain. They found that certain types of tumors, especially those from brain and other tissues, share similar patterns of spreading throughout the fly's body. Who this helps: This helps researchers who study cancer and develop treatments by providing better tools to understand how tumors spread.

Plain English
This study focused on three rare types of B-cell cancers: plasmablastic lymphoma, lymphomatoid granulomatosis, and intravascular lymphoma. Researchers found that plasmablastic lymphoma is aggressive, often linked to HIV, and benefits from new treatments like bortezomib and daratumumab. Lymphomatoid granulomatosis primarily affects the lungs, while intravascular lymphoma grows in blood vessels, with diagnosis and timely treatment being critical for better outcomes. Who this helps: This information benefits patients with rare B-cell malignancies and their doctors.

Plain English
This article looks at isotretinoin, a powerful medication used to treat severe acne. It has been around for almost 60 years, starting from early cancer research to being approved for acne treatment in 1982 due to its effectiveness and safety. The review also discusses ongoing concerns about risks like birth defects and links to depression, while exploring current uses of the drug in other medical fields. Who this helps: Patients with severe acne and healthcare providers.

Plain English
This research paper examined how the environment around tumors and the body's biology affect cancer spread using fruit flies (Drosophila) as a model. The study highlighted that Drosophila helps researchers understand important mechanisms of tumor growth and spread, which are crucial since metastasis is responsible for over 90% of cancer deaths. These insights can lead to better strategies for treating cancer and improving patient outcomes. Who this helps: This helps patients and doctors by providing new knowledge to fight cancer more effectively.

Plain English
This research looked at how important it is to use a placebo group when testing surgical and other procedural interventions. It found that procedures without a placebo often showed better outcomes, meaning that the positive effects of these procedures might be partly or mostly due to the placebo effect. For instance, the placebo effect accounted for up to 88.1% of the perceived improvement in exercise-related outcomes among trials. This matters because it suggests that some procedures may not be as effective as previously thought, highlighting the need for more rigorous testing. Who this helps: This helps patients and doctors better understand the true effectiveness of procedural treatments.

Plain English
This study focused on a 68-year-old heart transplant patient who developed a tough-to-treat condition called post-transplant lymphoproliferative disorder (PTLD). Traditional treatments didn’t work for him, but he experienced significant improvement after receiving CAR T-cell therapy, a new and advanced treatment for certain blood cancers. This finding is important because it shows that CAR T-cell therapy can be effective for patients with PTLD, offering a potentially life-saving option where standard treatments fail. Who this helps: This helps patients with post-transplant lymphoproliferative disorder.

Plain English
This study looked at the potential health benefits of extracts from the plant Oxalis corymbosa, focusing on its ability to fight bacteria and its antioxidant properties. Researchers found that the leaves had the highest levels of beneficial compounds like chlorophyll and carotenoid, while the roots contained more phenolic and flavonoid compounds. The extracts were effective against harmful bacteria, particularly against Staphylococcus aureus and E. coli, indicating that these plant parts could be valuable in developing health products. Who this helps: This helps patients and health product manufacturers.

Plain English
This research paper studied the health risks associated with pollution from chromite mining, particularly the toxic metals generated during the process. It found that toxic substances, like hexavalent chromium, pose serious health threats not only to miners but also to nearby residents, as these pollutants contaminate air, water, and soil. The study emphasizes the need for better safety measures and monitoring to protect affected communities and improve health outcomes for those exposed to these hazardous materials. Who this helps: This helps miners, residents near mining areas, and healthcare providers.

Plain English
The study examined the ethics of how doctors in Pakistan prescribe medications and found several key issues. It identified four main problems: the harmful effects of unethical prescribing, the reasons behind these practices (like financial pressure and lack of education), the types of unethical prescriptions (such as unnecessary or overly expensive drugs), and potential solutions (including better education and stricter laws). These findings highlight the need for improvements in how prescriptions are managed to safeguard patients' health and trust. Who this helps: This research benefits patients and healthcare providers in Pakistan.

Plain English
This study looked at a serious condition called fulminant cerebral edema (FCE) that can happen after CAR T-cell therapy, a treatment for certain types of blood cancers. The researchers shared the case of a 42-year-old man who died from FCE after receiving this therapy, highlighting the need to identify patients who might be at greater risk for this dangerous side effect. Understanding the risk factors is important because it can help doctors take better care of patients undergoing this treatment. Who this helps: This helps doctors and patients receiving CAR T-cell therapy.

Plain English
This study looked at the levels of fluoride in groundwater in the Quetta region of Balochistan, highlighting health risks from contaminated drinking water. Researchers found that 52% of the groundwater samples were unsafe to drink, with fluoride levels ranging from 0 to 3.4 mg/l. They identified that infants and children are particularly at risk, with hazard values indicating they are much more vulnerable compared to adults and teens. Who this helps: This helps patients, particularly young children and their families, in areas affected by high fluoride levels in drinking water.

Plain English
This study examined the genetic factors linked to adhesive capsulitis (a condition that causes shoulder stiffness) and compared them to those related to Dupuytren disease (a condition that affects hand function). Researchers found 6 significant genetic markers related to adhesive capsulitis and identified 13 genetic markers that are common between both conditions, suggesting they may have similar causes. These findings are important because understanding the genetic basis of these diseases could lead to better treatments and interventions. Who this helps: Patients suffering from adhesive capsulitis and Dupuytren disease.

Plain English
This study looked at a new treatment for patients with diffuse large B-cell lymphoma (DLBCL) using a combination of atezolizumab with the standard treatment, R-CHOP. The results showed that 77.5% of patients had a complete response to the treatment after 6-8 cycles, and after 3 years, about 77.4% of patients had not experienced disease progression, while 87.2% were still alive. Although most patients had some side effects, the treatment showed promising effectiveness and a safety profile that matched what is known about the drugs used. Who this helps: This benefits patients with DLBCL seeking more effective treatment options.

Plain English
This study looked at 12 patients treated for primary testicular lymphoma (PTL) at a medical center from 2010 to 2021. The research found that 25% of these patients relapsed within about 8 months after treatment, but on average, patients had about 50 months without progression of the disease. Understanding these patterns helps improve treatment strategies for this rare and aggressive cancer. Who this helps: This benefits patients diagnosed with primary testicular lymphoma and their doctors.

Plain English
This study looked at how two drugs, chloroquine and trastuzumab, work together to treat a type of breast cancer that is resistant to trastuzumab alone. The researchers found that chloroquine killed cancer cells more effectively than trastuzumab, with the maximum effect being about three times greater—0.0405 for chloroquine compared to 0.0125 for trastuzumab. This is important because combining these two medications could provide a new approach to treating patients with difficult-to-treat HER2-positive breast cancer. Who this helps: This helps patients suffering from HER2-positive breast cancer who are resistant to existing treatments.

Plain English
This study looked at treatment options for patients with gray zone lymphoma (GZL), a rare type of cancer, to see how these choices impact survival rates. Researchers analyzed data from over 1,000 patients and found that only about 16% received combined treatments (CMT) while the rest had chemotherapy alone. Those who received CMT had better survival rates, with a risk of death reduced by 46% compared to those on chemotherapy alone. Who this helps: This research helps patients with gray zone lymphoma by informing treatment decisions that can improve their chances of survival.

Plain English
This study focused on a rare type of brain cancer called primary dural lymphoma (PDL), which is a low-grade form of lymphoma. The researchers presented a case of a 39-year-old African American woman who had chronic headaches and was found to have a tumor on her brain's outer layer. After treatment with a combination of medications, the patient experienced complete remission, showing that this treatment was effective for PDL. Who this helps: Patients with primary dural lymphoma and their doctors.

Plain English
This study looked at patients in the UAE who had a procedure called pericardiocentesis, where fluid is removed from around the heart. Out of 33 patients, 22 (or 67%) had cancer as the cause of the fluid buildup, mainly from breast and lung cancer. Understanding that most patients experienced this can help doctors better manage care and improve outcomes for cancer patients. Who this helps: This helps doctors and cancer patients by providing crucial information for better treatment strategies.

Plain English
This study focused on improving ultrasound image quality by training a deep learning method using real patient data instead of relying solely on computer-generated simulations. The researchers found that their new method significantly enhanced image quality when using in vivo data, leading to better results than traditional techniques. This is important because it can lead to clearer and more accurate ultrasound images, which can improve patient diagnoses and treatment plans. Who this helps: Patients undergoing ultrasound examinations.

Plain English
This study looked at how exposure to heavy metals from dust affects the health of chromite mine workers. Researchers found that workers, especially those who extract the materials, had higher levels of harmful metals in their urine—specifically 51.34 micrograms of chromium and 34.29 micrograms of lead per gram of creatinine—along with signs of cell damage due to oxidative stress. The results indicate that mining workers are at increased risk for health problems related to metal exposure, highlighting the need for better safety measures at these job sites. Who this helps: This helps miners and occupational health regulators.

Plain English
This study explored neurological issues that some people experienced after receiving COVID-19 vaccinations. Four patients in Trinidad and Tobago developed significant neurological conditions shortly after their vaccinations, including seizures and Guillain-Barre syndrome. While these cases are concerning, it's important to note that such reactions are rare, and vaccines are still considered safe overall. Who this helps: This helps patients and doctors by highlighting the importance of monitoring rare vaccine side effects while reinforcing vaccine safety.

Plain English
This study looked at how a protein called Xrp1 impacts the way cells produce proteins and how they compete with each other when there are problems with ribosome function. It found that Xrp1 lowers protein production, which leads cells to outcompete healthier cells when there are issues with ribosomes. This has significant implications since understanding Xrp1's role in cell competition could help explain conditions like cancer, where cell competition is often involved. Who this helps: This research benefits patients with diseases related to ribosome dysfunction and their doctors.

Plain English
This study looked at how combining chemotherapy and radiation (called combined modality treatment or CMT) affects survival in older patients with primary central nervous system lymphoma (PCNSL) over 12 years. Researchers analyzed data from 6,537 patients and found that only 12.8% received CMT, and this number decreased from 17.7% in 2004 to 8.7% in 2015. Those who received CMT lived longer, with a median overall survival of 19.5 months compared to those on single treatments. Understanding these trends is crucial for improving treatment options and health outcomes for older patients. Who this helps: Patients with primary central nervous system lymphoma and their doctors.

Plain English
This study looked at a new treatment combining atezolizumab, obinutuzumab, and bendamustine for patients with newly diagnosed follicular lymphoma. Researchers found that 75% of patients had a complete response to the treatment, but there was an increased risk of severe side effects, including five deaths. The findings indicate that this combination therapy is not better than existing treatments and may be too risky for patients. Who this helps: This helps doctors and patients with follicular lymphoma understand the risks and benefits of new treatment options.

Plain English
The study looked at patients with diffuse large B-cell lymphoma (DLBCL) who had surgery before starting their main treatment. Researchers analyzed data from 2006 to 2015 and found that those who had surgery first experienced a longer wait for their initial treatment (34 days compared to 23 days) but had a five-year survival rate of 62.7% versus 58.3% for those who did not have surgery first, showing that surgery did not harm their chances of survival. Understanding the factors that influenced whether a patient had surgery first can help improve treatment decisions. Who this helps: This helps patients diagnosed with DLBCL and their doctors in understanding treatment options.

Plain English
This study looked at two treatment options for patients with Primary Central Nervous System Lymphoma (PCNSL) after initial chemotherapy: autologous stem cell transplantation (ASCT) and whole brain radiation therapy (WBRT). Researchers found that patients who received ASCT had a significantly better survival rate, with a 5-year survival of 74.4% compared to 58.7% for those who had WBRT. The study also revealed that only a small percentage (12.2%) of patients opted for ASCT, but this number has been increasing over time. Who this helps: This research benefits patients with PCNSL by highlighting a more effective treatment option and may inform doctors on treatment decisions.

Plain English
This study looked at how privatizing hospitals in Saudi Arabia has affected their efficiency from 1979 to 2020. The researchers found that hospitals that were fully privatized performed better overall compared to those that were less privatized; specifically, the more corporatized hospitals showed greater efficiency in managing resources. This matters because improving hospital efficiency can lead to better healthcare services for patients while reducing costs for the government. Who this helps: Patients and healthcare providers in Saudi Arabia.

Plain English
This research examined how different treatments affect survival outcomes for patients with primary breast lymphoma (PBL) in the U.S. Among 4,616 patients studied, those with aggressive PBL who received systemic therapy lived an average of 115 months, compared to 72 months for those who did not receive systemic therapy. In contrast, patients with indolent PBL had high survival rates with local treatments like surgery or radiation, with a 5-year survival of 87% when combining systemic therapy and radiation. Who this helps: This information benefits patients with primary breast lymphoma and their doctors by highlighting effective treatment options.

Plain English
This study looked at a new treatment for a serious side effect called immune effector cell-associated neurotoxicity syndrome (ICANS), which can occur after CAR T-cell therapy for blood cancers. The researchers treated two patients who didn't respond to standard steroid treatments with chemotherapy delivered directly into the spinal fluid, using 12 mg of methotrexate and 50 mg of hydrocortisone. Both patients showed quick improvement in their neurological symptoms, but one patient died from unrelated health issues, while the other is doing well without complications. This matters because it suggests a promising alternative for patients suffering from severe ICANS who do not respond to steroids. Who this helps: Patients with steroid-refractory ICANS after CAR T-cell therapy.

Plain English
This study looked at how well military veterans with severe PTSD can interpret emotions by examining people's eyes, a skill called social cognition. The researchers tested 47 veterans using a well-known test and found that their performance was normal, but having a service dog with them did not help improve their ability to read emotions. However, being with a service dog did make them search for visual information faster, which may indicate they felt less anxious in social situations. Who this helps: This benefits veterans with PTSD and those supporting their mental health.

Plain English
This study looked at a rare side effect of the cancer drug venetoclax in a 77-year-old man being treated for chronic lymphocytic leukemia. After two years on the medication, he developed vitiligo, a skin condition that causes loss of pigmentation, which is only the second reported case linked to this drug. While vitiligo doesn’t increase death risk, it can cause emotional stress, so close monitoring of the patient continued, and he remained healthy during treatment. Who this helps: This information helps patients with chronic lymphocytic leukemia and their doctors.

Plain English
This study focused on how to better visualize multiple myeloma (a type of cancer) in patients who have been treated with a drug called daratumumab. Researchers developed a special small antibody, called a nanobody, that can specifically identify myeloma cells even when daratumumab is being used. They found that this nanobody successfully attached to myeloma cells in lab tests and in mice treated with daratumumab, providing a clear imaging method that was not possible before. Who this helps: This benefits patients with multiple myeloma by improving the ability to monitor their disease during daratumumab treatment.

Plain English
This study focused on a treatment called glofitamab for patients whose diffuse large B-cell lymphoma (DLBCL) had returned or was resistant to previous therapies. Researchers found that 39% of the 155 patients who received glofitamab had a complete response to the treatment after a median follow-up of about 12.6 months, with many continuing to benefit after one year. The treatment showed promise despite some side effects, like cytokine release syndrome occurring in 63% of patients. Who this helps: This research benefits patients with relapsed or refractory DLBCL seeking new treatment options.

Plain English
This study looked at a gene called spn-A/rad51 in fruit flies and how its absence affects their health and development. Researchers found that when this gene is missing, the flies experience more damage to their cells, increased cell death, and problems growing in cooler temperatures. Specifically, the flies showed visible defects in their abdomen and only slight issues in their wings and eyes. This research is significant because it highlights the essential role of the spn-A/rad51 gene in maintaining healthy body tissues. Who this helps: This helps researchers and doctors understand genetic functions related to cell repair, which could inform treatments for related health conditions in humans.

Plain English
This study developed a new method called ADMIRE to enhance ultrasound images by reducing noise and unwanted clutter. Using advanced graphics cards, the researchers achieved a remarkable speed increase, processing images 100 times faster than traditional methods, making real-time imaging possible with ultrasound machines. This is important because clearer and more precise images can lead to better diagnoses and treatments for patients. Who this helps: Patients undergoing ultrasound examinations.

Plain English
This study looked at whether progesterone vaginal pessaries (400 mg twice a day) are just as effective as progesterone vaginal gel (90 mg once a day) in helping women achieve clinical pregnancies after in vitro fertilization (IVF). Both treatments showed similar clinical pregnancy rates: 38.3% for pessaries and 39.9% for the gel, meaning the pessaries worked just as well. This is important because it offers women an effective treatment option that is equally safe and tolerated during IVF. Who this helps: This benefits women undergoing IVF treatments.

Plain English
This study looked at the safety of using fluoroquinolones, a type of antibiotic, in children under 18 years old, focusing on their potential to cause muscle and bone problems. Researchers analyzed data from over a million Korean children and found that those treated with fluoroquinolones had a 19% higher risk of experiencing musculoskeletal issues compared to those given amoxicillin, particularly in boys and older children. Understanding this risk is important for making safe treatment choices for young patients. Who this helps: This helps doctors and healthcare providers treating children with infections.

Plain English
This study focused on how temperature affects the movement of light waves in a special type of liquid crystal material known as nematic liquid crystals. The researchers found that by adjusting the temperature, they could predict the paths of these light waves (called nematicons) very accurately. This matters because it helps improve the control and manipulation of light in various applications, which could lead to advancements in technology like displays and optical communication. Who this helps: This benefits researchers and engineers working in optical technologies.